X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TTK HEALTHCARE - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON TTK HEALTHCARE BIOCON /
TTK HEALTHCARE
 
P/E (TTM) x 18.1 16.3 110.9% View Chart
P/BV x 2.9 1.6 180.5% View Chart
Dividend Yield % 0.4 1.0 41.5%  

Financials

 BIOCON    TTK HEALTHCARE
EQUITY SHARE DATA
    BIOCON
Mar-18
TTK HEALTHCARE
Mar-19
BIOCON /
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,1881,215 97.8%   
Low Rs305610 50.0%   
Sales per share (Unadj.) Rs68.7444.4 15.5%  
Earnings per share (Unadj.) Rs7.617.2 43.8%  
Cash flow per share (Unadj.) Rs14.027.6 50.6%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %0.10.5 24.4%  
Book value per share (Unadj.) Rs86.3177.9 48.5%  
Shares outstanding (eoy) m600.0014.13 4,246.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.92.1 528.9%   
Avg P/E ratio x98.952.9 186.8%  
P/CF ratio (eoy) x53.433.0 161.8%  
Price / Book Value ratio x8.65.1 168.6%  
Dividend payout %13.229.0 45.7%   
Avg Mkt Cap Rs m447,90012,894 3,473.6%   
No. of employees `0006.12.3 266.0%   
Total wages/salary Rs m9,3111,307 712.4%   
Avg. sales/employee Rs Th6,705.82,715.7 246.9%   
Avg. wages/employee Rs Th1,514.2565.3 267.9%   
Avg. net profit/employee Rs Th736.9105.4 699.1%   
INCOME DATA
Net Sales Rs m41,2346,279 656.7%  
Other income Rs m2,06278 2,660.6%   
Total revenues Rs m43,2966,356 681.2%   
Gross profit Rs m8,291496 1,672.9%  
Depreciation Rs m3,851147 2,625.1%   
Interest Rs m61534 1,819.5%   
Profit before tax Rs m5,887393 1,499.5%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569149 1,053.7%   
Profit after tax Rs m4,531244 1,859.3%  
Gross profit margin %20.17.9 254.7%  
Effective tax rate %26.737.9 70.3%   
Net profit margin %11.03.9 283.1%  
BALANCE SHEET DATA
Current assets Rs m41,4862,717 1,526.8%   
Current liabilities Rs m21,4131,571 1,363.2%   
Net working cap to sales %48.718.3 266.6%  
Current ratio x1.91.7 112.0%  
Inventory Days Days6432 198.9%  
Debtors Days Days9447 201.9%  
Net fixed assets Rs m50,661991 5,112.1%   
Share capital Rs m3,000141 2,123.1%   
"Free" reserves Rs m48,8082,373 2,056.8%   
Net worth Rs m51,8082,514 2,060.5%   
Long term debt Rs m17,8983 526,411.8%   
Total assets Rs m99,8974,158 2,402.5%  
Interest coverage x10.612.6 83.8%   
Debt to equity ratio x0.30 25,547.3%  
Sales to assets ratio x0.41.5 27.3%   
Return on assets %5.26.7 77.2%  
Return on equity %8.79.7 90.2%  
Return on capital %9.616.9 56.9%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m12,058225 5,354.4%   
Fx outflow Rs m7,34871 10,333.3%   
Net fx Rs m4,710154 3,056.7%   
CASH FLOW
From Operations Rs m6,621173 3,825.0%  
From Investments Rs m-6,84097 -7,088.1%  
From Financial Activity Rs m-2,397-307 780.0%  
Net Cashflow Rs m-2,612-38 6,928.4%  

Share Holding

Indian Promoters % 40.4 65.4 61.8%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 3.7 227.0%  
FIIs % 10.7 5.2 205.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 25.8 77.1%  
Shareholders   109,995 12,723 864.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  SHASUN PHARMA  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling, HDFC Q1FY20 Results, and Top Cues in Focus Today(Pre-Open)

India share markets ended their day deep in the red yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 305 points (down 0.8%).

Related Views on News

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 22, 2019 (Close)

TRACK BIOCON

BIOCON - ALEMBIC PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS